Diana Koszycki1,2,3, Jennifer Thake1, Céline Mavounza4, Jean-Philippe Daoust1,2, Monica Taljaard1,5, Jacques Bradwejn1,2,3. 1. 1 University of Ottawa , Ottawa, Ontario, Canada . 2. 2 Institut de recherche de l'Hôpital Montfort , Ottawa, Ontario, Canada . 3. 3 University of Ottawa Brain and Mind Research Institute , Ottawa, Ontario, Canada . 4. 4 Université Laval , Québec, Québec, Canada . 5. 5 Ottawa Hospital Research Institute , Ottawa, Ontario, Canada .
Abstract
OBJECTIVES: This study evaluated the feasibility and initial efficacy of a 12-week group mindfulness-based intervention tailored for persons with social anxiety disorder (MBI-SAD). The intervention includes elements of the standard mindfulness-based stress reduction program, explicit training in self-compassion aimed at cultivating a more accepting and kinder stance toward oneself, and use of exposure procedures to help participants practice responding mindfully to internal experiences evoked by feared social situations. METHODS: Participants were randomly assigned to the MBI-SAD (n = 21) or a waitlist (WL) (n = 18) control group. Feasibility was assessed by the number of participants who completed at least 75% of the 12 weekly group sessions. Primary efficacy outcomes were clinician- and self-rated measures of social anxiety. Other outcomes included clinician ratings of illness severity and self-rated depression, social adjustment, mindfulness, and self-compassion. RESULTS: The MBI-SAD was acceptable and feasible, with 81% of participants attending at least 75% of sessions. The MBI-SAD fared better than WL in improving social anxiety symptom severity (p ≤ 0.0001), depression (p ≤ 0.05), and social adjustment (p ≤ 0.05). The intervention also enhanced self-compassion (p ≤ 0.05), and facets of mindfulness (observe and aware; p ≤ .05). MBI-SAD treatment gains were maintained at 3-month follow-up. CONCLUSIONS: These preliminary findings suggest that an MBI that integrates explicit training in self-compassion and mindful exposure is a feasible and promising intervention for social anxiety disorder. The next step is to compare the MBI-SAD to the gold standard of cognitive-behavior therapy to determine equivalence or noninferiority and to explore mediators and moderators of treatment outcome.
RCT Entities:
OBJECTIVES: This study evaluated the feasibility and initial efficacy of a 12-week group mindfulness-based intervention tailored for persons with social anxiety disorder (MBI-SAD). The intervention includes elements of the standard mindfulness-based stress reduction program, explicit training in self-compassion aimed at cultivating a more accepting and kinder stance toward oneself, and use of exposure procedures to help participants practice responding mindfully to internal experiences evoked by feared social situations. METHODS:Participants were randomly assigned to the MBI-SAD (n = 21) or a waitlist (WL) (n = 18) control group. Feasibility was assessed by the number of participants who completed at least 75% of the 12 weekly group sessions. Primary efficacy outcomes were clinician- and self-rated measures of social anxiety. Other outcomes included clinician ratings of illness severity and self-rated depression, social adjustment, mindfulness, and self-compassion. RESULTS: The MBI-SAD was acceptable and feasible, with 81% of participants attending at least 75% of sessions. The MBI-SAD fared better than WL in improving social anxiety symptom severity (p ≤ 0.0001), depression (p ≤ 0.05), and social adjustment (p ≤ 0.05). The intervention also enhanced self-compassion (p ≤ 0.05), and facets of mindfulness (observe and aware; p ≤ .05). MBI-SAD treatment gains were maintained at 3-month follow-up. CONCLUSIONS: These preliminary findings suggest that an MBI that integrates explicit training in self-compassion and mindful exposure is a feasible and promising intervention for social anxiety disorder. The next step is to compare the MBI-SAD to the gold standard of cognitive-behavior therapy to determine equivalence or noninferiority and to explore mediators and moderators of treatment outcome.
Authors: Natalie L Marchant; Thorsten Barnhofer; Olga M Klimecki; Géraldine Poisnel; Antoine Lutz; Eider Arenaza-Urquijo; Fabienne Collette; Miranka Wirth; Ann-Katrin Schild; Nina Coll-Padrós; Leslie Reyrolle; Deborah Horney; Pierre Krolak-Salmon; José Luis Molinuevo; Zuzana Walker; Aline Maillard; Eric Frison; Frank Jessen; Gael Chételat Journal: Alzheimers Dement (N Y) Date: 2018-12-14
Authors: Elisabeth Akeman; Evan White; Kate Wolitzky-Taylor; Jessica Santiago; Timothy J McDermott; Danielle C DeVille; Jennifer L Stewart; Martin Paulus; Charles T Taylor; Robin L Aupperle Journal: Behav Modif Date: 2021-07-12
Authors: James Douglas Bremner; Sanskriti Mishra; Carolina Campanella; Majid Shah; Nicole Kasher; Sarah Evans; Negar Fani; Amit Jasvant Shah; Collin Reiff; Lori L Davis; Viola Vaccarino; James Carmody Journal: Front Psychiatry Date: 2017-08-25 Impact factor: 4.157